• Profile
Close

Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): A pragmatic, open-label, randomised controlled trial

The Lancet Jan 12, 2019

Naslund U, et al. - A total of 3,532 subjects recruited between April 29, 2013 and June 7, 2016 were assessed to examine the role of ultrasound-based pictorial information regarding subclinical carotid atherosclerosis (targeting both primary care physicians and patients) for prevention of cardiovascular disease in a randomized controlled trial. Individuals aged 40, 50, or 60 years with one or more conventional risk factors were eligible. Researchers observed a decline in Framingham risk score (FRS) from baseline to 1-year follow-up in the intervention group and an increase in the control group. They determined a contributory role of pictorial presentation of silent atherosclerosis for the prevention of cardiovascular disease. They also suggested medication and lifestyle modifications to reduce the prevalence of cardiovascular disease.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay